Avascular Necrosis Market Research Report – Forecast to 2030

Avascular Necrosis Market Research Report By Type (Trauma Related Avascular Necrosis (AVN) and Non-Trauma Related Avascular Necrosis (AVN), By Site (Hip Bone, Knee, Shoulder and Other), By Diagnosis(Imaging, Biopsy, Total, CT Scan, PET and X- Ray), By Treatment (Medication, Electrical Stimulation, Gene Therapy and Surgery), By End-User(Hospitals & Clinics, Diagnostic Centers and Ambulatory Surgical Centers), By Region – Forecast to 2030

ID: MRFR/MED/4673-CR | 539 Pages | Published By Kinjoll Dey on June 2018         

Avascular Necrosis Market Speak to Analyst Request a Free Sample

Avascular Necrosis Market

The Avascular Necrosis Market size is projected to grow at a CAGR 6.5% and is expected to reach USD 704.2 Million in the forecast period

By Type Trauma Related Avascular Necrosis and Non-Trauma Related Avascular Necrosis
By Site Hip Bone Knee Shoulder and Other
By Diagnosis Imaging Biopsy Total CT Scan PET and X- Ray
By Treatment Medication Electrical Stimulation Gene Therapy and Surgery
By End-User Hospitals & Clinics Diagnostic Centers and Ambulatory Surgical Centers
Key Players
Companies Profiled   Novartis AG   Pfizer Inc.   Teva Pharmaceutical Industries Ltd.   Mylan N.V.   Zimmer Biomet   Merck & Co. Inc.   Enzo Biochem Inc.   Atnahs   Bone Therapeutics SA   Vericel Corporation
Market Driving Forces   Rising Presence of surgeries to cure osteanecrosis.
Request a Free Sample

Avascular Necrosis Market Overview:

The Avascular Necrosis Market is expected to reach USD 704.2 Million by 2030 at 6.5% CAGR during the forecast period 2022-2030. Avascular necrosis is a kind of disease which occurs from the short-term or permanent loss of blood supply to the bone in your body. Such types of cut-off of blood supply to the bone lead to small breaks in the bone sides, and these bines eventually fall. Avascular necrosis disease is also known as osteonecrosis. These things may happen in any part of your body, but generally, it occurs mostly in the long bone. The bone that might be broken or dislocated joint can easily interrupt the blood circulation section inside your body part. Normally people around the age of 30 to 50 may face this disease.

Avascular necrosis is also called aseptic necrosis or osteonecrosis, or ischemic bone necrosis, which brings about the death of bone cells inside your body due to the lack of blood supply. It can frequently lead the joint surface fall and the consequent joint inflammation because of the irregularity in your body's joint surface. Avascular necrosis impacts the closure joints of long bones, including the upper humerus, lower leg joint bones and femurs. Generally, it occurs due to several factors such as genetic problems, metabolic, alcohol consumption, smoking or some kinds of different alignments. To get the perfect cure for this disease or to treat avascular necrosis, non-surgical treatments have been used. The anti-inflammation medication crutches are the most important source of treatment which assists in removing the disease as well as relieving the pain in your body. The surgical treatment normally comprises bone grafting and the cartilage or entire hip replacement or core decompression method. The increasing percentage of alcohol consumption for a long time and high dose of systematic corticosteroid utilization is one of the significant risk factors for avascular necrosis.

Some of the other serious factors are including such non-traumatic osteonecrosis that occurs in cancer, autoimmune illness, Gaucher disorders, HIV infection, pancreatitis, blood tissues, decompression illness that is a caisson ailment, sickle cell infection happens. The immediate treatment for such diseases like chemotherapy as well as radiation treatment might cause osteonecrosis. However, all the individuals who have experienced organ transplants suffer from a high risk of osteonecrosis disease.

Some of the advanced medical technologies related to the treatment procedures for avascular necrosis, like advanced therapy medicinal products, will definitely assist the Avascular Necrosis market growth. In the present world, to gain the proper cure for the disease, several modern and advanced medical equipment and machines have been successfully made, due to which in most cases people can get rid of their disease.

COVID- 19 Analysis:

The sudden outbreak of the COVID-19 pandemic has led to a significant impact on the avascular necrosis market. As a result, the import and export activities of the market have been stopped for a long period of time. Due to the world health emergency of a global epidemic, most of the manufacturing and production work has been stopped for a period of time. The governments from several regions have issued a strict lockdown procedure for which all the international travel and trade routes have been closed for a long time. Due to the strict lockdown, most of the trade ships didn't receive their destination. The investors have faced a huge loss in their business as well as all the factories, and the avascular necrosis market share have been crashed for a long period of time. The major challenge for the new market players is how to overcome this pandemic situation.

During the pandemic, the Medicare equipment and the advanced research product to found the cure have been demanding increasingly for which most of the new market players come in the market to meet the challenge on the global market.

The Chief Factors Existing in the Avascular Necrosis Market:

Key Market Drivers:

The increasing income percentage of people and several business professionals and the tremendous growth of the world population has led these market sectors so hugely. Therefore, most prominent market players want to increase their production rate to meet the specific demand of people from around the world. 

Market Challenges:

The most effective challenge in the avascular necrosis market is how to overcome this global pandemic situation. Due to the stoppage of production work and the lockdown of international trade, the trading business sectors and the entire market sectors have faced a huge loss.

Market opportunities:

Just after the release of strict lockdown, several regions give an opportunity to the market’s most recent players who wants to come up in the avascular necrosis market want also want to compete with the most prominent players. Due to this, the new faces in the business sectors also increased significantly. The entire production or manufacturing work also increased so high in the avascular necrosis market.

Market restraints:

Due to the COVID-19 outbreak, the cost of manufacturing equipment, raw materials, and labor has also increased so high.

Cumulative Evaluation of the Market:

Raising awareness of health consciousness is one of the most prominent challenges in the present Avascular Necrosis market. Not only for these sectors but also increasing the health awareness to get rid of several diseases is the most important factor in this modern era. According to the market latest report, the advanced technological equipment and most in-depth research establishment have also increased in this present market significantly. Due to this, several Medicare products and advanced hospital research equipment have come up in this market. During the lockdown, the entire market was stopped for a long period of time. But just after the realization of lockdown, most of the new market players have entered this market to face the new challenges in making the disease cures.

Avascular Necrosis Market Segmentation:

According to the avascular necrosis market analysis report, the market has been segmented into six several sections type, site, diagnosis, treatment, end-user and regional sectors. In terms of the type sections, the market has been categorized into two sections trauma-related avascular necrosis no-trauma related avascular necrosis. With the site section, it is further divided into four parts hip bone, knee, shoulder and other. In terms of the diagnosis, it is further classified into two categories like imaging & biopsy. The treatment section is further divided into four parts medication, electrical stimulation, gene therapy and surgery. By the end-user part, the entire Avascular Necrosis market share has been classified into three sections hospitals & clinics, diagnostic centers, ambulatory surgical centers. According to the regional basis, it is classified into five sections: Asia-Pacific, Europe, South America, North America, and Middle East & Africa.

Regional Analysis:

As per the market report, North America has been expected to hold the largest Avascular Necrosis market growth in the world market sectors. In addition, the 65 age group of people have been facing this disease. But in developing countries, the good establishment of medical sectors and modern equipment can easily lead the market into the growth ahead. But the rising health awareness in such a country is one of the most important factors. In terms of the new treatment options as well as the development of modern medical infrastructure can lead the market to grow within this estimated projected period of time.

Competitive Intensity within the Industry:

The significant impact on the avascular necrosis market and the impact on the global business sector s are completely placed in this market report. Due to the health emergency period, most businesses and investors want to invest their funds to increase production according to the challenge of global demand. That’s why most of industries prominent key players make some interest to enlarge their production. 

  • Novartis AG

  • Pfizer Inc.

  • Teva Pharmaceutical Industries Ltd.

  • Mylan N.V.

  • Zimmer Biomet

  • Merck & Co. Inc.

  • Enzo Biochem Inc.

  • Atnahs

  • Bone Therapeutics SA

  • Vericel Corporation

Recent market Development:

The market players are continuously focusing on gaining drug & alcohol-consuming consumption from the regulatory bodies, which is expected to boost the avascular necrosis market growth during the upcoming period. In December 2020, Novartis AG announced the European Commission had permitted the treatment of the Youngers with hypercholesterolemia or mixed dyslipidemia. Leave is one of the first-class small interfering RNA that provides effective and sustained LDL-C reduction for patients with atherosclerotic cardiovascular disease.

Report Overview:

The avascular necrosis market report completely understands avascular necrosis and its symptoms and treatments. The reports also provide details on the market key players and the improvement of modern medical equipment. Some new generic medicines and the raising of global market shares have also been included in this report. The impact of the global epidemic and the raising of the global market and some of the industry's key players with their modern business-related works are also included in this report.

Key Industrial Segments:

By Type: 

  • Trauma-related avascular necrosis

  • Non-trauma-related avascular necrosis 

By site:

  • Hip Bone

  • Knee

  • Shoulder

  • Other

By Diagnosis:

  • Imaging

  • Biopsy 

By Treatment:

  • Medication

  • Electrical Stimulation

  • Gene Therapy

  • Surgery


  • Hospitals & Clinic

  • Diagnosis Centers

  • Ambulatory Surgical Centers

Regional Analysis: 

  • Asia-Pacific

  • Europe

  • North America

  • South America

  • Middle East & Africa 

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Projected Avascular Necrosis Market CAGR would be 6.5% during the forecast period of 2022-2030.

The players taking part are Medtronic plc, Ethicon Inc., Stryker Corporation, Bayer AG, Sanofi SA, Merck KGaA, Pfizer Inc., Eli Lilly and Company, Aurobindo Pharma, Boehringer Ingelheim GmbH, Zimmer Biomet Holdings, Integra LifeSciences Corporation, Grifols SA, Wright Medical Group N.V., and Smith and Nephew.

Avascular Necrosis Market valuation would be USD 704.2 Million by 2030.

Strict government regulations would hold back Avascular Necrosis Market growth.

The Imaging segment would lead Avascular Necrosis Market.